Medical Care in China

Ovarian cancer
Treatment in China

Provide a clear and complete coordinated pathway from expert assessment to treatment and rehabilitation.

Get a Care Plan and Cost Estimate
Gynecological disease diagnosis and treatmentcovers diseases of the uterus, ovaries, cervix and pelvic floor.
Gynecologic tumor treatmentprovides surgical and comprehensive treatment options.
Reproductive medicine supportincludes assessments for complex infertility and recurrent pregnancy failure.
Management of high-risk pregnancies involvesmultidisciplinary collaboration to address complex pregnancy issues.

Condition Guide

About Ovarian cancer

Understand the condition, common triggers and treatment options that may require specialist assessment.

Disease Introduction

Ovarian cancer is known as the "king of gynecological cancers." Early symptoms are often subtle, and it is often discovered at an advanced stage. It is most common in postmenopausal women. Treatment is based on surgery and chemotherapy, and targeted maintenance therapy can significantly prolong survival.


Cutting-edge high-precision diagnostic and treatment technologies

  1. FRα-targeted ADC : Somituximab, the first ADC in China targeting folate receptor α (FRα), was upgraded from conditional approval to routine approval in November 2025. It is used for FRα-positive, platinum-resistant recurrent ovarian cancer, and its objective response rate and progression-free survival are significantly better than chemotherapy.
  2. PARP maintenance therapy : Olaparib and niraparib were included in the 2025 guidelines for first-line maintenance therapy. Patients with BRCA mutations or HRD positivity can significantly delay relapse and prolong progression-free survival by taking PARP inhibitors after remission from platinum-based chemotherapy.
  3. Hyperthermic intraperitoneal perfusion : Hyperthermic intraperitoneal perfusion chemotherapy (HIPEC) can be added to the treatment of stage III patients after neoadjuvant chemotherapy and intermittent cytoreductive surgery. The ASCO 2025 guidelines recommend that chemotherapy drugs be heated to 42-43°C and perfused into the peritoneal cavity at the same time as cytoreductive surgery to increase local drug concentration and kill microresidual lesions.
  4. Bevacizumab anti-angiogenesis : Bevacizumab combined with chemotherapy and maintenance therapy is used for first-line and some relapsed patients with advanced disease. It continuously blocks tumor angiogenesis by inhibiting the VEGF pathway. When combined with PARP inhibitors, it can further prolong progression-free survival in BRCA wild-type patients.

Care Overview

Ovarian cancer Treatment in China

The medical team will develop a personalized protocol based on the pathology type, stage, genetic test, previous treatment history, and the patient's physical condition.

Leading Specialists

Trusted Expertise Across Leading Specialties

Chen Zijiang

Academician of the Chinese Academy of Sciences, Academician of the Academy of Sciences for the Developing World, Chief Expert of the Reproductive Center, and Director of the Shanghai Key Laboratory of Assisted Reproduction and Eugenics.

Obstetrics & Gynecology

Research Areas : Basic and clinical research in reproductive endocrinology and assisted reproductive technology. Cutting-Edge Technology: In collaboration with Sun Yun's team, initiated a multicenter randomized controlled clinical trial on the "Efficacy of Prednisone in Treating Recurrent Implantation Failure," demonstrating that indiscriminate use of prednisone may actually increase the risk of preterm birth. The research findings were published in *JAMA*. Areas of Expertise: Reproductive endocrine disor

Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo Affiliated Hospital Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Gao Minzhi

Chief Physician, Doctor of Medicine, Master's Supervisor.

Obstetrics & Gynecology

Research areas : Diagnosis and treatment of infertility and reproductive endocrine disorders, and assisted reproductive technologies. Cutting-edge technologies: Proficient in assisted reproductive technologies such as artificial insemination and in-vitro fertilization-embryo transfer (IVF), and has extensive experience in the comprehensive management of reproductive endocrine disorders. Areas of Expertise: Infertility, reproductive endocrine disorders (polycystic ovary syndrome, ovulation disorders, etc.)

Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo Affiliated Hospital Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Sui Long

Chief Physician, Professor, Director of the Intrauterine Disease Center

Obstetrics & Gynecology

-Research areas : Intrauterine diseases, cervical diseases, minimally invasive hysteroscopic surgery; - Areas of expertise: separation of severe intrauterine adhesions, hysteroscopic resection of giant submucosal fibroids, and correction of uterine malformations; - Areas of expertise: Severe intrauterine adhesions, uterine septum, cesarean section incision diverticulum, cervical lesions; - Academic Highlights & Core Values: A leading authority in the field of hysteroscopy in China, spearheading the develo

Obstetrics and Gynecology Hospital Affiliated to Fudan University (Shanghai Red House Gynecology Hospital) logo Affiliated Hospital Obstetrics and Gynecology Hospital Affiliated to Fudan University (Shanghai Red House Gynecology Hospital)
Li Xiaotian

Chief Physician, Professor, Doctoral Supervisor, Former Director of Obstetrics

Obstetrics & Gynecology

-Research areas : High-risk obstetrics, prenatal diagnosis, maternal-fetal medicine; - Areas of expertise: 5-minute immediate cesarean section, comprehensive treatment of placenta previa with high risk, fetal medicine; - Areas of expertise: Placenta previa with severe complications, amniotic fluid embolism, severe preeclampsia, and complex high-risk pregnancies; - Academic Highlights & Core Values: A promoter of the construction of a high-risk obstetric emergency care system in China, and the creator of t

Obstetrics and Gynecology Hospital Affiliated to Fudan University (Shanghai Red House Gynecology Hospital) logo Affiliated Hospital Obstetrics and Gynecology Hospital Affiliated to Fudan University (Shanghai Red House Gynecology Hospital)
Li Zheng

Chief Physician, Professor, Doctoral Supervisor, Head of the Reproductive Andrology Subspecialty

Obstetrics & Gynecology

-Research areas : male infertility, male reproductive endocrinology, spermatogenesis disorders; - Areas of expertise: Testicular microsurgical sperm retrieval, sperm freezing, and treatment of severe oligospermia and asthenospermia; - Areas of expertise: Non-obstructive azoospermia, severe oligoasthenospermia, male gonadal dysfunction; - Academic Highlights & Core Values: Head of the Shanghai Human Sperm Bank, a leading expert in male reproductive medicine in China, and the founder of a comprehensive diag

Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo Affiliated Hospital Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Zhao Xiaoming

A French-trained PhD, chief physician, former director and party branch secretary of the Department of Reproductive Medicine, and one of the earliest experts in Shanghai to engage in assisted reproductive technology.

Obstetrics & Gynecology

Research Areas : Reproductive endocrine disorders, infertility, especially assisted reproductive technology; researching and optimizing individualized ovulation induction protocols and improving endometrial receptivity for complex cases such as recurrent implantation failure and assisted reproduction in older women. Cutting-Edge Technologies: Led the establishment of the Department of Reproductive Medicine at Renji Hospital, achieving several breakthroughs within the National Chiao Tung University School

Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo Affiliated Hospital Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Patient Stories

See the Next Step Through Patient Journeys

Sequelae of Pelvic Inflammatory Disease (Tubal Infertility) - Unblocking the CASE 01
PATIENT JOURNEY

Sequelae of Pelvic Inflammatory Disease (Tubal Infertility) - Unblocking the "Origin" of Life

Obstetrics & Gynecology

Patient records Name: Sopheap Chea Age: 36 Nationality: Cambodia Diagnosis: Sequelae of pelvic inflammatory disease (tubal infertility) Treatment Hospital: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences “All my test results are 'normal,' but the baby just won’t come.” Sopheap, 36, a gentle woman of Chinese descent from Phnom Penh, Cambodia, had been trying to conceive for five years without success. She underwent every possible test in Cambodia, including a hysterosalpingogr

View case details →
Giant Uterine Leiomyoma - A Precise Blade to Unravel the CASE 02
PATIENT JOURNEY

Giant Uterine Leiomyoma - A Precise Blade to Unravel the "Fog" in the Abdomen

Obstetrics & Gynecology

Patient records Name: Kanya Wattana Age: 29 Nationality: Thailand Diagnosis: Giant uterine leiomyoma Treatment Hospital: Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine “It felt like I had a grapefruit stuck in my stomach, but I couldn’t leave any ‘battle medals’ behind.” Kanya, 29, from Phuket, Thailand, is a bikini model. She sought medical attention for excessive menstrual bleeding and a mass in her abdomen, where she discovered a massive uterine fibroid measuring 12

View case details →
Complete Placenta Previa with Placenta Accreta - Defused the CASE 03
PATIENT JOURNEY

Complete Placenta Previa with Placenta Accreta - Defused the "Time Bomb" Between Mother and Infant

UrologyObstetrics & Gynecology

Patient records Name: Sari Dewi Age: 32 Nationality: Indonesia Diagnosis: Complete placenta previa complicated by placenta accreta Treatment Hospital: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology “The doctor told me that my placenta, like a tree root, had penetrated my uterus and grown onto my bladder. The risk of severe bleeding during childbirth is extremely high, and I might not even survive.” Sari, 32, from Surabaya, Indonesia, is a mother of two. Her voice

View case details →
Polycystic Ovary Syndrome - Breaking the CASE 04
PATIENT JOURNEY

Polycystic Ovary Syndrome - Breaking the "Curse" of Adolescence

Obstetrics & Gynecology

Patient records Name: Thiri Aung Age: 19 Nationality: Myanmar Diagnosis: Polycystic ovary syndrome Treatment Hospital: Obstetrics and Gynecology Hospital Affiliated to Fudan University (Red House Hospital) “I felt like an inflated balloon, looking at my face covered in acne and excess fat in the mirror, I felt like a stranger.” Thiri, a 19-year-old girl from Yangon, Myanmar, was contacted by her mother online . Her voice was soft on the other end of the phone . In the past two years, she had gained 20 k

View case details →

Next Step

Get a Care Plan
and Cost Estimate.

Tell us about your diagnosis and needs, and our team will help screen the right hospital and explain the next steps.

Email:goldentcm@163.com

Get a Care Plan and Estimate

Once you submit your information, a member of our support team will reach out to you within one business day.